SPWM
Spartan Planning & Wealth Management Portfolio holdings
AUM
$117M
This Quarter Return
-1.53%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$74.9M
AUM Growth
+$74.9M
(-6.3%)
Cap. Flow
+$2.78M
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
83.05%
Holding
165
New
22
Increased
33
Reduced
36
Closed
51
Top Buys
| 1 |
iShares Short Treasury Bond ETF
SHV
|
$16.8M |
| 2 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$15M |
| 3 |
ClearShares Ultra-Short Maturity ETF
OPER
|
$2.12M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.28M |
| 5 |
Kellanova
K
|
$722K |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$6.05M |
| 2 |
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
$5.5M |
| 3 |
iShares Core US REIT ETF
USRT
|
$3.51M |
| 4 |
Apple
AAPL
|
$3.24M |
| 5 |
Microsoft
MSFT
|
$3.15M |
Sector Composition
| 1 | Consumer Staples | 4.24% |
| 2 | Healthcare | 4.16% |
| 3 | Energy | 1.77% |
| 4 | Technology | 1.71% |
| 5 | Industrials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$100B
| $245K | 0.33% |
871
-89
| -9% | -$25K |
|
27
Pfizer
PFE
$141B
| $236K | 0.32% |
4,506
+2,206
| +96% | +$116K |
|
28
Leidos
LDOS
$23.2B
| $227K | 0.3% |
2,250
| – | – |
|
29
Waters Corp
WAT
$18B
| $225K | 0.3% |
+679
| New | +$225K |
|
30
C.H. Robinson
CHRW
$15.2B
| $219K | 0.29% |
+2,162
| New | +$219K |
|
31
AbbVie
ABBV
$372B
| $213K | 0.28% |
1,389
+780
| +128% | +$120K |
|
32
Valero Energy
VLO
$47.2B
| $213K | 0.28% |
2,000
+1,900
| +1,900% | +$202K |
|
33
Eli Lilly
LLY
$657B
| $204K | 0.27% |
628
+350
| +126% | +$114K |
|
34
Bunge Global
BG
$16.8B
| $182K | 0.24% |
+2,009
| New | +$182K |
|
|
35
Vanguard Total Stock Market ETF
VTI
$526B
| $177K | 0.24% |
936
-32,003
| -97% | -$6.05M |
|
36
Colgate-Palmolive
CL
$67.9B
| $169K | 0.23% |
+2,108
| New | +$169K |
|
37
Schlumberger
SLB
$55B
| $155K | 0.21% |
+4,338
| New | +$155K |
|
38
American Tower
AMT
$95.5B
| $152K | 0.2% |
+593
| New | +$152K |
|
39
Kimberly-Clark
KMB
$42.8B
| $151K | 0.2% |
+1,115
| New | +$151K |
|
40
Chevron
CVX
$324B
| $145K | 0.19% |
1,002
+345
| +53% | +$49.9K |
|
41
Philip Morris
PM
$260B
| $130K | 0.17% |
1,316
+842
| +178% | +$83.2K |
|
42
Bristol-Myers Squibb
BMY
$96B
| $128K | 0.17% |
1,658
+622
| +60% | +$48K |
|
43
Oneok
OKE
$48.1B
| $122K | 0.16% |
+2,191
| New | +$122K |
|
44
Baker Hughes
BKR
$44.8B
| $121K | 0.16% |
+4,188
| New | +$121K |
|
45
Cheniere Energy
LNG
$53.1B
| $119K | 0.16% |
+897
| New | +$119K |
|
46
Linde
LIN
$224B
| $116K | 0.15% |
403
-598
| -60% | -$172K |
|
47
Gilead Sciences
GILD
$140B
| $114K | 0.15% |
+1,845
| New | +$114K |
|
48
Quest Diagnostics
DGX
$20.3B
| $109K | 0.15% |
+823
| New | +$109K |
|
49
ConocoPhillips
COP
$124B
| $108K | 0.14% |
1,202
-1,670
| -58% | -$150K |
|
50
AT&T
T
$209B
| $108K | 0.14% |
+5,167
| New | +$108K |
|